|
1
|
European Association for The Study of The
Liver European Organisation for Research and Treatment of Cancer, .
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
International Agency for Research on
Cancer (IARC), . About CANCERMondial. http://www-dep.iarc.fr/January 11–2013.
|
|
3
|
Breous E and Thimme R: Potential of
immunotherapy for hepatocellular carcinoma. J Hepatol. 54:830–834.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greten TF, Manns MP and Korangy F:
Immunotherapy of hepatocellular carcinoma. J Hepatol. 45:868–878.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Palmer DH, Midgley RS, Mirza N, Torr EE,
Ahmed F, Steele JC, Steven NM, Kerr DJ, Young LS and Adams DH: A
phase II study of adoptive immunotherapy using dendritic cells
pulsed with tumor lysate in patients with hepatocellular carcinoma.
Hepatology. 49:124–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mizukoshi E, Nakamoto Y, Arai K, Yamashita
T, Sakai A, Sakai Y, Kagaya T, Yamashita T, Honda M and Kaneko S:
Comparative analysis of various tumor-associated antigen-specific
T-cell responses in patients with hepatocellular carcinoma.
Hepatology. 53:1206–1216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mellman I, Coukos G and Dranoff G: Cancer
immunotherapy comes of age. Nature. 480:480–489. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Butterfield LH, Ribas A, Dissette VB, Lee
Y, Yang JQ, De la Rocha P, Duran SD, Hernandez J, Seja E, Potter
DM, et al: A phase I/II trial testing immunization of
hepatocellular carcinoma patients with dendritic cells pulsed with
four alpha-fetoprotein peptides. Clin Cancer Res. 12:2817–2825.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sawada Y, Yoshikawa T, Nobuoka D,
Shirakawa H, Kuronuma T, Motomura Y, Mizuno S, Ishii H, Nakachi K,
Konishi M, et al: Phase I trial of a glypican-3-derived peptide
vaccine for advanced hepatocellular carcinoma: Immunologic evidence
and potential for improving overall survival. Clin Cancer Res.
18:3686–3696. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, Zeng H, Xu RH, Liu B and Li Z:
Vaccination with human pluripotent stem cells generates a broad
spectrum of immunological and clinical responses against colon
cancer. Stem Cells. 27:3103–3111. 2009.PubMed/NCBI
|
|
11
|
Yaddanapudi K, Mitchell RA, Putty K,
Willer S, Sharma RK, Yan J, Bodduluri H and Eaton JW: Vaccination
with embryonic stem cells protects against lung cancer: Is a
broad-spectrum prophylactic vaccine against cancer possible? PLoS
One. 7:e422892012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong W, Du J, Shen H, Gao D, Li Z, Wang G,
Mu X and Liu Q: Administration of embryonic stem cells generates
effective antitumor immunity in mice with minor and heavy tumor
load. Cancer Immunol Immunother. 59:1697–1705. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mocan T and Iancu C: Effective colon
cancer prophylaxis in mice using embryonic stem cells and carbon
nanotubes. Int J Nanomed. 6:1945–1954. 2011. View Article : Google Scholar
|
|
14
|
Zhang ZJ, Chen XH, Chang XH, Ye X, Li Y
and Cui H: Human embryonic stem cells - a potential vaccine for
ovarian cancer. Asian Pac J Cancer Prev. 13:4295–4300. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schoenhals M, Kassambara A, De Vos J, Hose
D, Moreaux J and Klein B: Embryonic stem cell markers expression in
cancers. Biochem Biophys Res Commun. 383:157–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brewer BG, Mitchell RA, Harandi A and
Eaton JW: Embryonic vaccines against cancer: An early history. Exp
Mol Pathol. 86:192–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ben-David U and Benvenisty N: The
tumorigenicity of human embryonic and induced pluripotent stem
cells. Nat Rev Cancer. 11:268–277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao W, Ji X, Zhang F, Li L and Ma L:
Embryonic stem cell markers. Molecules. 17:6196–6236. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mishra L, Banker T, Murray J, Byers S,
Thenappan A, He AR, Shetty K, Johnson L and Reddy EP: Liver stem
cells and hepatocellular carcinoma. Hepatology. 49:318–329. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oishi N and Wang XW: Novel therapeutic
strategies for targeting liver cancer stem cells. Int J Biol Sci.
7:517–535. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akhurst B, Croager EJ, Farley-Roche CA,
Ong JK, Dumble ML, Knight B and Yeoh GC: A modified
choline-deficient, ethionine-supplemented diet protocol effectively
induces oval cells in mouse liver. Hepatology. 34:519–522. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tirnitz-Parker JE, Tonkin JN, Knight B,
Olynyk JK and Yeoh GC: Isolation, culture and immortalisation of
hepatic oval cells from adult mice fed a choline-deficient,
ethionine-supplemented diet. Int J Biochem Cell Biol. 39:2226–2239.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dumble ML, Croager EJ, Yeoh GC and Quail
EA: Generation and characterization of p53 null transformed hepatic
progenitor cells: Oval cells give rise to hepatocellular carcinoma.
Carcinogenesis. 23:435–445. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang P, Liu T, Cong M, Wu X, Bai Y, Yin C,
An W, Wang B, Jia J and You H: Expression of extracellular matrix
genes in cultured hepatic oval cells: An origin of hepatic stellate
cells through transforming growth factor beta? Liver Int.
29:575–584. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Conner DA: Mouse embryo fibroblast (MEF)
feeder cell preparation. Curr Protoc Mol Biol. 2001.Chapter 23:
Unit 23.2: May 1, 2001 (Epub ahead of primt). doi:
10.1002/0471142727.mb2302s51. View Article : Google Scholar :
|
|
26
|
Xu C, Huang HR, Yu H, Zhao XL, Lu YL, Dai
LC and Yao X: The study of separating murine embryonic fibroblast
from embryonic stem cells by the differential adhesion method. Fen
Zi Xi Bao Sheng Wu Xue Bao. 39:477–481. 2006.(In Chinese).
PubMed/NCBI
|
|
27
|
Dhodapkar MV and Dhodapkar KM: Vaccines
targeting cancer stem cells: Are they within reach? Cancer J.
17:397–402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oertel M: Fetal liver cell transplantation
as a potential alternative to whole liver transplantation? J
Gastroenterol. 46:953–965. 2011. View Article : Google Scholar : PubMed/NCBI
|
